News

Lilly, Junshi Biosciences to co-develop antibody-based therapies for COVID-19

Lilly will receive an exclusive license to conduct clinical development, manufacturing and distribution of products outside of Greater China.

Read More

May 07, 2020

By : By Team ABLE

IIT Delhi start up Nanosafe launches antimicrobial and washable face mask NSafe

NSafe mask is an engineered triple-layered product consisting of inner hydrophilic layer for comfort, middle layer with antimicrobial activity and outer most layer having water and oil repellent behaviour.

Read More

May 07, 2020

By : By Team ABLE

CSIR releases Compendium of Indian Technologies for combating COVID-19

The compendium carries information about 200 COVID-19-related Indian technologies, ongoing research activities, technologies available for commercialisation, initiatives and efforts taken by the Govt of India.

Read More

May 07, 2020

By : By Team ABLE

CEPI launches a new Call for Proposals to accelerate COVID-19 vaccine development and production

Focus for funding will be on vaccine candidates that have the potential to be developed rapidly and manufactured globally at scale

Read More

May 06, 2020

By : Team ABLE

Pfizer, BioNTech dose first participants in USA as part of global COVID-19 MRNA vaccine development program

First participants were dosed at NYU Grossman School of Medicine and University of Maryland School of Medicine

Read More

May 06, 2020

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights